Stock Events

Stock Events

Search...

Bellevue Group

CHF8.02

17

+CHF0+0% Today

Statistics

Day High

8.04

Day Low

7.92

52W High

12.4

52W Low

7

Volume

10,371

Avg. Volume

22,952

Mkt Cap

0

P/E Ratio

-

Dividend Yield

1.87%

Dividend

0.15

Upcoming

Dividend Payment

Dividend Payment

Dividends

1.87%Dividend Yield

Mar 26

CHF0.15

Mar 25

CHF0.7

Mar 24

CHF1.15

Mar 23

CHF2

Mar 22

CHF2.7

10Y Growth

-17.28%

5Y Growth

-36.9%

3Y Growth

-57.83%

1Y Growth

-78.57%

Earnings

24FebExpected

Q4 2022

Q2 2023

Q4 2023

Q2 2024

Q4 2024

Q2 2025

Q4 2025

999

333

-333

-999

Expected EPS

N/A

Actual EPS

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BBN.SW. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Novartis is a global healthcare company that competes with Bellevue in the pharmaceutical and healthcare investment sectors.

Roche Holding AG is a major player in the pharmaceuticals and diagnostics market, directly competing with Bellevue's investments in healthcare.

Pfizer is a leading pharmaceutical company, competing with Bellevue in the healthcare and pharmaceutical investment space.

Merck & Co., Inc. is a global healthcare company that competes with Bellevue through its pharmaceutical products and healthcare solutions.

Johnson & Johnson

Johnson & Johnson is a comprehensive healthcare firm that competes across various segments, including pharmaceuticals, medical devices, and consumer health products.

AbbVie is a biopharmaceutical company that competes with Bellevue in the healthcare investment sector, particularly in pharmaceuticals.

Amgen is a biotechnology firm competing with Bellevue in the biopharmaceutical investment space.

GlaxoSmithKline is a global healthcare company, competing with Bellevue in pharmaceuticals and healthcare products.

Bristol-Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company, competing with Bellevue in the development and commercialization of pharmaceuticals.

Sanofi is a global biopharmaceutical company competing with Bellevue in the healthcare and pharmaceutical sectors.

About

Bellevue Group AG provides asset management services in Switzerland, the United Kingdom, Germany, and internationally. The company offers healthcare investment solutions, including biotech, medtech, thematic, and healthcare global and regional. It also provides small and mid-sized entrepreneur investment solutions, such as listed small and mid caps, and private equity strategies; and multi asset, bonds, and alternatives. In addition, the company offers investment funds, as well as investment solutions for institutional, intermediary and private clients. The company was founded in 1993 and is headquartered in Zurich, Switzerland.

Show more...

CEO

ISIN

CH0028422100

Listings

0 Comments

Share your thoughts

FAQ

What is Bellevue Group stock price today?▼

The current price of BBN.SW is CHF8.02 CHF — it has increased by +0% in the past 24 hours. Watch Bellevue Group stock price performance more closely on the chart.

What is Bellevue Group stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Bellevue Group stocks are traded under the ticker BBN.SW.

Is Bellevue Group stock price growing?▼

BBN.SW stock has risen by +1.01% compared to the previous week, the month change is a -8.64% fall, over the last year Bellevue Group has showed a -9.05% decrease.

Does Bellevue Group pay dividends?▼

Yes, BBN.SW dividends are paid annual. The last dividend per share was 0.15 CHF. As of today, Dividend Yield (FWD)% is 1.87%.

When did Bellevue Group complete a stock split?▼

Bellevue Group has not had any recent stock splits.